Highly sensitive cardiac troponin T and long-term mortality in a population of community-derived perimenopausal women: Nested case-control study

Heart

Volumn 99, Issue 8, 2013, Pages 528-533

  Cramer, G Etienne ^a   Brouwer, Marc A ^a   Vader, Huib L ^b   De Boer, Menko Jan ^a   Pop, Gheorghe A M ^a   Pop, Victor J M ^c   Verheugt, Freek W A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MÁXIMA MEDICAL CENTER   (Netherlands)

^c TILBURG UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; HORMONE; TROPONIN T;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; BODY MASS; CLIMACTERIUM; COHORT ANALYSIS; COMMUNITY SAMPLE; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MORTALITY; NETHERLANDS; OSTEOPOROSIS; POPULATION BASED CASE CONTROL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE VALUE; RISK FACTOR;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; NETHERLANDS; ODDS RATIO; PEPTIDE FRAGMENTS; PERIMENOPAUSE; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TROPONIN T; UP-REGULATION;

EID: 84875234622     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302829     Document Type: Article

References (28)

1. Ridker PM, Hennekens CH, Buring JE, et al. C-Reactive Protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43. (Pubitemid 30165206)
2. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207.
3. Melander O, Newton-Cheh C, Almgren P, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009;302:49-57.
4. Zethelius B, Berglund L, Sundström J, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008;358:2107-16. (Pubitemid 351679597)
5. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655-63. (Pubitemid 38364624)
6. Korngold EC, Januzzi JL Jr, Gantzer ML, et al. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein as predictors of sudden death among women. Circulation 2009;119:2868-76.
7. Rutten JWH, Mattace-Raso FUS, Steyerberg EW, et al. Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population. Hypertension 2010;55:785-91.
8. Wallace TW, Abdullah SM, Drazner MH, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006;113:1958-65.
9. Eggers KM, Lind L, Ahlström H, et al. Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur heart J 2008;29:2252-8.
10. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men. Circulation 2006;113:1071-8.
11. Blankenberg S, Zeller T, Saarela O, et al. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation 2010;121:2388-97.
12. Daniels LB, Laughlin GA, Clopton P, et al. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults. J Am Coll Cardiol 2008;52:450-9. (Pubitemid 352040812)
13. Omland T, de Lemos JA, Sabatine MS, et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009;361:2538-47.
14. Laufer EM, Mingels MA, Winkens MHM, et al. The extent of coronary atherosclerosis is associated with increasing circulating levels of highly sensitive cardiac troponin T. Arterioscler Thromb Vasc Biol 2010;30:1269-76.
15. Korosoglou G, Lehrke S, Mueller D, et al. Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. Heart 2011;97:823-31.
16. Koenig W, Breitling LP, Hahmann H, et al. Cardiac troponin T measured by a high-sensitive assay predicts recurrent cardiovascular events in stable coronary artery disease patients with 8-year follow-up. Clin Chem 2012;58:1215-24.
17. Hallén J, Johansen OE, Birkeland KI, et al. Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitus. Cardiovasc Diabetol 2010;9:52.
18. deLemos JA, Drazner MH, Omland T, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010;304:2503-12.
19. deFilippi CR, deLemos JA, Christenson RH, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010;304:2494-502.
20. Saunders JT, Nambi V, deLemos JA, et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study. Circulation 2011;123:1367-76.
21. Agarwal SK, Avery CL, Ballantyne CM, et al. Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study. Clin Chem 2011;57:891-7.
22. Giannitsis E, Kurz K, Hallermayer K, et al. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254-61.
23. Mingels A, Jacobs L, Michielsen E, et al. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009;55:101-8.
24. Collison PO, Heung YM, Gaze D, et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 2012;58:219-25.
25. Twerenbold R, Jaffe A, Reichlin T, et al. High-sensitive troponin T measurements: what do we gain and what are the challenges? Eur Heart J 2012;33:579-86.
26. Everett BM, Cook NR, Magnone MC, et al. Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the women's health study. Circulation 2011;123:2811-18.
27. Smeets-Goevaers CG, Lesusink GL, Papapoulos SE, et al. The prevalence of low bone mineral density in dutch perimenopausal women: the Eindhoven perimenopausal osteoporosis study. Osteoporosis Int 1998;8:404-9. (Pubitemid 28486706)
28. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012;58:1574-81.